Serum alpha-foetoprotein level predicts treatment outcome in chronic hepatitis C.

Abstract

In this study, higher baseline serum AFP levels independently predicted a lower SVR rate among patients with chronic hepatitis C. If confirmed with genotypes other than 4, these findings would suggest adding serum AFP to the list of factors predictive of treatment response.